Atovaquone
CAS No. 95233-18-4
Atovaquone( BW 566C | BW 556C-80 )
Catalog No. M16808 CAS No. 95233-18-4
Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 10MG | 41 | In Stock |
|
| 25MG | 77 | In Stock |
|
| 50MG | 137 | In Stock |
|
| 100MG | 184 | In Stock |
|
| 200MG | 276 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtovaquone
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
-
DescriptionAtovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
-
In Vitro——
-
In VivoAnimal Model:ICSBP?/??mice infected with 10 cysts of the ME49 strain of?T. gondii Dosage:100 mg/kg Administration:Oral administration Result:Improved mice survival rate to 22 days compared to vehicle.
-
SynonymsBW 566C | BW 556C-80
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorDHODH| Cytochrome b
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number95233-18-4
-
Formula Weight366.84
-
Molecular FormulaC22H19ClO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 5 mg/mL (13.62 mM)
-
SMILESO=C1C([C@H]2CC[C@H](C3=CC=C(Cl)C=C3)CC2)=C(O)C(C4=C1C=CC=C4)=O
-
Chemical Nametrans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Winter RW, et al. Exp Parasitol. 2008 Apr; 118(4):487-97.
molnova catalog
related products
-
SW209049
SW209049 is a stearoyl-CoA 9-desaturase inhibitor. SW209049 exhivits potent activity against H2122 cell with IC50 of 0.13uM.
-
Enoxolone
Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption.
-
DHODH-IN-16
DHODH-IN-16 is an effective inhibitor of dihydroorotate dehydrogenase (DHODH, IC50 = 0.396 nM for human).
Cart
sales@molnova.com